Detalhe da pesquisa
1.
Design of Broadly Cross-Reactive M Protein-Based Group A Streptococcal Vaccines.
J Immunol
; 207(4): 1138-1149, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341168
2.
Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein-derived peptides.
J Biol Chem
; 295(12): 3826-3836, 2020 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32029479
3.
Structure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccine.
Vaccine
; 41(40): 5841-5847, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596198
4.
Serum Immune Responses to Group A Streptococcal Antigens following Pharyngeal Acquisitions among Children in Cape Town, South Africa.
mSphere
; 8(3): e0011323, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154726
5.
The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice.
J Infect Dis
; 201(10): 1580-8, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20367460
6.
Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.
Vaccine
; 38(6): 1384-1392, 2020 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843270
7.
Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against Streptococcus pyogenes.
mSphere
; 3(6)2018 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30567901
8.
Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.
J Pediatric Infect Dis Soc
; 6(2): 187-196, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28204534
9.
Trivalent M-related protein as a component of next generation group A streptococcal vaccines.
Clin Exp Vaccine Res
; 6(1): 45-49, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28168173
10.
Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
Vaccine
; 35(1): 19-26, 2017 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27890396
11.
Streptococcal pharyngitis in schoolchildren in Bamako, Mali.
Pediatr Infect Dis J
; 34(5): 463-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25356953
12.
Protective immunogenicity of group A streptococcal M-related proteins.
Clin Vaccine Immunol
; 22(3): 344-50, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25630406
13.
Group A streptococcus expresses a trio of surface proteins containing protective epitopes.
Clin Vaccine Immunol
; 21(10): 1421-5, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25080552
14.
Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.
Vaccine
; 32(40): 5241-9, 2014 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25077423
15.
Potential coverage of a multivalent M protein-based group A streptococcal vaccine.
Vaccine
; 31(12): 1576-81, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23375817
16.
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.
Vaccine
; 29(46): 8175-8, 2011 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21920403
17.
Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.
Vaccine
; 28(31): 5017-22, 2010 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20546830